Texas Capital Bank Wealth Management Services’s Cognition Therapeutics CGTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$93.6K Hold
123,296
0.01% 337
2025
Q4
$166K Buy
+123,296
New +$200K 0.01% 325
2024
Q4
Sell
-55,395
Closed -$26K 170
2024
Q3
$26K Hold
55,395
﹤0.01% 198
2024
Q2
$92K Hold
55,395
0.01% 187
2024
Q1
$101K Hold
55,395
0.01% 189
2023
Q4
$102K Buy
+55,395
New +$73.3K 0.01% 191

Other funds holding CGTX

Texas Capital Bank Wealth Management Services's CGTX Position: Q1 2026 in Review

Texas Capital Bank Wealth Management Services held its Cognition Therapeutics (CGTX) position steady in Q1 2026 at 123,296 shares worth $93.6K. The position accounts for 0.01% of the portfolio, ranked #337.

Texas Capital Bank Wealth Management Services first reported a position in CGTX in Q4 2023 and has held it in 6 quarters since. The position peaked at $166K in Q4 2025. 75 funds tracked by Wall St. Rank hold CGTX as of Q1 2026.

  • Texas Capital Bank Wealth Management Services held 123,296 shares of Cognition Therapeutics worth $93.6K as of Q1 2026.
  • Texas Capital Bank Wealth Management Services left its Cognition Therapeutics share count unchanged in Q1 2026.
  • Cognition Therapeutics made up 0.01% of Texas Capital Bank Wealth Management Services's portfolio in Q1 2026, its #337 holding.
  • Texas Capital Bank Wealth Management Services first reported a position in Cognition Therapeutics in Q4 2023 and has held it in 6 quarters since.
  • Texas Capital Bank Wealth Management Services's Cognition Therapeutics position peaked at $166K in Q4 2025.
  • 75 funds tracked by Wall St. Rank held Cognition Therapeutics as of Q1 2026.

Based on Texas Capital Bank Wealth Management Services's 13F filing for Q1 2026, filed 11 May 2026.